
Seung H. Lee
Examiner (ID: 8709, Phone: (571)272-2401 , Office: P/2887 )
| Most Active Art Unit | 2876 |
| Art Unit(s) | 2887, 2876 |
| Total Applications | 2203 |
| Issued Applications | 1831 |
| Pending Applications | 152 |
| Abandoned Applications | 248 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7056512
[patent_doc_number] => 20050277687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-15
[patent_title] => 'Combination of selected analgesics and COX-II inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/133190
[patent_app_country] => US
[patent_app_date] => 2005-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9230
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0277/20050277687.pdf
[firstpage_image] =>[orig_patent_app_number] => 11133190
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/133190 | Combination of selected analgesics and COX-II inhibitors | May 19, 2005 | Issued |
Array
(
[id] => 6967191
[patent_doc_number] => 20050234088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Urea substituted imidazoquinoline ethers'
[patent_app_type] => utility
[patent_app_number] => 11/132900
[patent_app_country] => US
[patent_app_date] => 2005-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15658
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20050234088.pdf
[firstpage_image] =>[orig_patent_app_number] => 11132900
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/132900 | Urea substituted imidazoquinoline ethers | May 18, 2005 | Issued |
Array
(
[id] => 5667646
[patent_doc_number] => 20060172996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Method of preventing relapse in the abstinent substance dependent individual'
[patent_app_type] => utility
[patent_app_number] => 11/126742
[patent_app_country] => US
[patent_app_date] => 2005-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2821
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20060172996.pdf
[firstpage_image] =>[orig_patent_app_number] => 11126742
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/126742 | Method of preventing relapse in the abstinent substance dependent individual | May 11, 2005 | Abandoned |
Array
(
[id] => 5189165
[patent_doc_number] => 20070167474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin'
[patent_app_type] => utility
[patent_app_number] => 11/579900
[patent_app_country] => US
[patent_app_date] => 2005-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14154
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167474.pdf
[firstpage_image] =>[orig_patent_app_number] => 11579900
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/579900 | Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin | May 11, 2005 | Abandoned |
Array
(
[id] => 7172255
[patent_doc_number] => 20050203052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Inosine compounds and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/122956
[patent_app_country] => US
[patent_app_date] => 2005-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17017
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203052.pdf
[firstpage_image] =>[orig_patent_app_number] => 11122956
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/122956 | Inosine compounds and methods of use thereof | May 3, 2005 | Abandoned |
Array
(
[id] => 5259768
[patent_doc_number] => 20070213400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'ALCOHOL-METABOLISM ENHANCING COMPOSITION AND INGESTA CONTAINING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 11/568079
[patent_app_country] => US
[patent_app_date] => 2005-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6771
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20070213400.pdf
[firstpage_image] =>[orig_patent_app_number] => 11568079
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/568079 | ALCOHOL-METABOLISM ENHANCING COMPOSITION AND INGESTA CONTAINING THE SAME | May 1, 2005 | Abandoned |
Array
(
[id] => 7046130
[patent_doc_number] => 20050250725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Regulation of the P21 gene and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/112354
[patent_app_country] => US
[patent_app_date] => 2005-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7107
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250725.pdf
[firstpage_image] =>[orig_patent_app_number] => 11112354
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/112354 | Regulation of the P21 gene and uses thereof | Apr 21, 2005 | Abandoned |
Array
(
[id] => 7188077
[patent_doc_number] => 20050192271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Use of selective chloride channel modulators to treat alcohol and/or stimulant substance abuse'
[patent_app_type] => utility
[patent_app_number] => 11/111435
[patent_app_country] => US
[patent_app_date] => 2005-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22226
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20050192271.pdf
[firstpage_image] =>[orig_patent_app_number] => 11111435
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/111435 | Use of selective chloride channel modulators to treat alcohol and/or stimulant substance abuse | Apr 20, 2005 | Abandoned |
Array
(
[id] => 6925455
[patent_doc_number] => 20050238710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Vitamin replacement as a hangover ameliorative'
[patent_app_type] => utility
[patent_app_number] => 11/110122
[patent_app_country] => US
[patent_app_date] => 2005-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1314
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20050238710.pdf
[firstpage_image] =>[orig_patent_app_number] => 11110122
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/110122 | Vitamin replacement as a hangover ameliorative | Apr 19, 2005 | Abandoned |
Array
(
[id] => 7051396
[patent_doc_number] => 20050187283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Method of treating deficits associated with brain injury'
[patent_app_type] => utility
[patent_app_number] => 11/110423
[patent_app_country] => US
[patent_app_date] => 2005-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6216
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187283.pdf
[firstpage_image] =>[orig_patent_app_number] => 11110423
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/110423 | Method of treating deficits associated with brain injury | Apr 19, 2005 | Abandoned |
Array
(
[id] => 5527814
[patent_doc_number] => 20090197891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'Use of (4-Alkylpiperazinyl)(phenyl) methanones in the treatment of alzheimer\'s disease'
[patent_app_type] => utility
[patent_app_number] => 10/599952
[patent_app_country] => US
[patent_app_date] => 2005-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8406
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197891.pdf
[firstpage_image] =>[orig_patent_app_number] => 10599952
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/599952 | Use of (4-Alkylpiperazinyl)(phenyl) methanones in the treatment of alzheimer's disease | Apr 11, 2005 | Abandoned |
Array
(
[id] => 44076
[patent_doc_number] => 07776858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-17
[patent_title] => 'Methods of treatment of chronic pain using eszopiclone'
[patent_app_type] => utility
[patent_app_number] => 11/099078
[patent_app_country] => US
[patent_app_date] => 2005-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5264
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/776/07776858.pdf
[firstpage_image] =>[orig_patent_app_number] => 11099078
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/099078 | Methods of treatment of chronic pain using eszopiclone | Apr 4, 2005 | Issued |
Array
(
[id] => 566659
[patent_doc_number] => 07465729
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-16
[patent_title] => 'Methods of treatment of menopause and perimenopause using eszopiclone'
[patent_app_type] => utility
[patent_app_number] => 11/099155
[patent_app_country] => US
[patent_app_date] => 2005-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4758
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/465/07465729.pdf
[firstpage_image] =>[orig_patent_app_number] => 11099155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/099155 | Methods of treatment of menopause and perimenopause using eszopiclone | Apr 4, 2005 | Issued |
Array
(
[id] => 803362
[patent_doc_number] => 07423066
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-09
[patent_title] => 'Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism'
[patent_app_type] => utility
[patent_app_number] => 11/099134
[patent_app_country] => US
[patent_app_date] => 2005-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20348
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/423/07423066.pdf
[firstpage_image] =>[orig_patent_app_number] => 11099134
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/099134 | Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism | Apr 3, 2005 | Issued |
Array
(
[id] => 7046172
[patent_doc_number] => 20050250767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Use of N-desmethylclozapine to treat human neuropsychiatric disease'
[patent_app_type] => utility
[patent_app_number] => 11/098892
[patent_app_country] => US
[patent_app_date] => 2005-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20554
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250767.pdf
[firstpage_image] =>[orig_patent_app_number] => 11098892
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/098892 | Use of N-desmethylclozapine to treat human neuropsychiatric disease | Apr 3, 2005 | Abandoned |
Array
(
[id] => 5754637
[patent_doc_number] => 20060223786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Transdermal pain control method and device'
[patent_app_type] => utility
[patent_app_number] => 11/097878
[patent_app_country] => US
[patent_app_date] => 2005-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4399
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20060223786.pdf
[firstpage_image] =>[orig_patent_app_number] => 11097878
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/097878 | Transdermal pain control method and device | Mar 31, 2005 | Abandoned |
Array
(
[id] => 7051416
[patent_doc_number] => 20050187303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set'
[patent_app_type] => utility
[patent_app_number] => 11/090979
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 27220
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187303.pdf
[firstpage_image] =>[orig_patent_app_number] => 11090979
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/090979 | Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set | Mar 24, 2005 | Abandoned |
Array
(
[id] => 4720134
[patent_doc_number] => 20080242657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Treatment of Tremor with Histamine H3 Inverse Agonists or Hist Amine H3 Antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/593933
[patent_app_country] => US
[patent_app_date] => 2005-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6194
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20080242657.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593933
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593933 | Treatment of Tremor with Histamine H3 Inverse Agonists or Hist Amine H3 Antagonists | Mar 21, 2005 | Abandoned |
Array
(
[id] => 8244976
[patent_doc_number] => 08202907
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-19
[patent_title] => 'Composition with preventive or improvement effect on symptoms or diseases associated with stress-induced behavior disorders'
[patent_app_type] => utility
[patent_app_number] => 11/663076
[patent_app_country] => US
[patent_app_date] => 2005-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6884
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/202/08202907.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663076
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663076 | Composition with preventive or improvement effect on symptoms or diseases associated with stress-induced behavior disorders | Mar 17, 2005 | Issued |
Array
(
[id] => 5760720
[patent_doc_number] => 20060211665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Reduction of postoperative pain medication'
[patent_app_type] => utility
[patent_app_number] => 11/083183
[patent_app_country] => US
[patent_app_date] => 2005-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1563
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211665.pdf
[firstpage_image] =>[orig_patent_app_number] => 11083183
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/083183 | Reduction of postoperative pain medication | Mar 16, 2005 | Abandoned |